Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05ICF
|
|||
Former ID |
DNC014569
|
|||
Drug Name |
1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione
|
|||
Synonyms |
CHEMBL296771; 1,3-bis(4-methylphenyl)-1,3-diazetidine-2,4-dione; 1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione; AC1MRG54; SCHEMBL19214040
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H14N2O2
|
|||
Canonical SMILES |
CC1=CC=C(C=C1)N2C(=O)N(C2=O)C3=CC=C(C=C3)C
|
|||
InChI |
1S/C16H14N2O2/c1-11-3-7-13(8-4-11)17-15(19)18(16(17)20)14-9-5-12(2)6-10-14/h3-10H,1-2H3
|
|||
InChIKey |
AZZFGWWOGRBVOV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cationic trypsinogen (PRSS1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Pancreatic secretion | ||||
Protein digestion and absorption | ||||
Influenza A | ||||
Reactome | Activation of Matrix Metalloproteinases | |||
Cobalamin (Cbl, vitamin B12) transport and metabolism | ||||
WikiPathways | Activation of Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.